Plasma norepinephrine, plasma renin activity, and congestive heart failure: Relations to survival and the effects of therapy in V-HeFT II

Circulation

Volumn 87, Issue 6 SUPPL. 1, 1993, Pages

  Francis, Gary S ^a   Cohn, Jay N ^a   Johnson, Gary ^a   Rector, Thomas S ^a   Goldman, Steven ^a   Simon, Ada ^a  

^a NONE

Author keywords

Congestive heart failure; Neurohormones; Norepinephrine; Renin

Indexed keywords

ENALAPRIL; HYDRALAZINE; ISOSORBIDE DINITRATE; NEUROHORMONE; NORADRENALIN; PRORENIN; RENIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; EXERCISE TOLERANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORADRENALIN BLOOD LEVEL; OXYGEN CONSUMPTION; PHASE 3 CLINICAL TRIAL; PLASMA RENIN ACTIVITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

COMPARATIVE STUDY; DRUG THERAPY, COMBINATION; ENALAPRIL; HEART FAILURE, CONGESTIVE; HUMAN; HYDRALAZINE; ISOSORBIDE DINITRATE; MALE; MIDDLE AGE; NOREPINEPHRINE; RENIN; RISK FACTORS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SURVIVAL ANALYSIS;

EID: 0027167633     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Francis GS, Goldsmith SR, Lcvine TB, Olivari MT, Cohn JN: The neurohumoral axis in congestive heart failure. Ann Intern Med 1984;101:370-377
2. Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN: Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in congestive heart failure. Am J Cardial 1982;49:1659-1666
3. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector TS: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823
4. Cohn JN, Archibald D, Ziesche S, Franciosa JA, Harston WE, Tristani F, Dunkman B, Jacobs W, Francis G, Flohr K, Goldman S, Cobb F, Shah P, Saunders R, Fletcher R, Loeb H, Hughes V, Baker B: Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative Study (V-HeFT). N Engl J Med 1986;314:1547-1552
5. The CONSENSUS Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435
6. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302
7. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis GS, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat G, Goldman S, Fetcher RD, Doherty J, Carson P, Cintron G, Shabetai R, Haakenson C: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure: V-HeFT II.N Engl J Med 1991;325:303-310
8. Passon PG, Peuler JD: A simplified radiometric assay for plasma norepinephrine and epinephrine. Anal Biochem 1973;51:618-631
9. Sealey JE, Gerten-Banes J, Laragh JH: The renin system: Variations in man measured by radioimmunoassay or bioassay. Kidney Int 1972;1:240-253
10. Rector TS, Olivari MT, Levine TB, Francis GS, Cohn JN: Predicting survival for an individual with congestive heart failure using plasma norepinephrine concentration. Am Heart J 1987;114: 148-152
11. Francis GS, Boosalis PJ: Mechanisms of death in patients with congestive heart failure: The change in plasma norepinephrine and its relation to sudden death or death from progressive pump failure. Cardioscience 1990;1:29-32
12. Rockman HA, Juneau C, Chatterjee K, Rouleau J-L: Long-term predictors of sudden and low-output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1989:64:1344-1348
13. Swedberg K. Eneroth P, Kjekshus J, Wilhelmson L, CONSENSUS Trial Study Group: Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990;82:1730-1736
14. Cody RJ, Couit AB, Schaer GL, Laragh JH, Sealey JE, Feldschuh J: Sodium and water balance in chronic congestive heart failure. J Clin Invest 1986;77:1441-1452
15. Brown JJ, Davies DL, Johnson VW, Lever AF, Robertson JIS: Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J 1970;80:329-342
16. Curtiss C, Cohn JN, Vrobel T, Franciosa JA: Role of the reninangiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 1978;58:763-776
17. Dzau VJ, Colucci WS, Hollenberg NK, Williams GH: Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981;63:645-651
18. Benge W, Litchfield RL, Marcus ML: Exercise capacity in patients with severe left ventricular dysfunction. Circulation 1980;61: 955-959
19. Franciosa JA, Park M, Levine TB: Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-39
20. Litchfield RL, Kerber RE, Benge JW, Mark AL, Sopko J, Bhatnager RK: Normal exercise capacity in patients with severe left ventricular dysfunction: Compensatory mechanisms. Circulation 1982;66:129-134
21. Kao W, Gheorghiade M, Hall V, Goldstein S: Relation between plasma norepinephrine and response to medical therapy in men with congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1989;64: 609-613
22. Francis GS, Rector TS, Cohn JN: Sequential neurohumoral measurements in patients with congestive heart failure. Am Heart J 1988;116:1464-1468
23. Story DF, Ziogas J: Interaction of angiotensin with noradrenergic neuroeffector transmission. Trends Pharmacol Sci 1987;8:269-271
24. Benjamin N, Collier JG, Webb DJ: Angiotensin II augments sympathetically induced venoconstriction in man. Clin Sci 1988;75: 337-340
25. Molderings GJ, Likungu J, Hentrich F, Gothert M: Facilitatory presynaptic angiotensin receptors on the sympathetic nerves of the human saphenous vein and pulmonary artery: Potential involvement in β-adrenoceptor-mediated facilitation of noradrenaline release. Arch Pharmacol 1988;338:228-233
26. Szabo B, Hedler L, Schurr C, Starke K: Peripheral presynaptic facilitatory effect of angiotensin II on noradrenaline release in anesthetized rabbits. J Cardiovasc Pharmacol 1990;15:968-975
27. Goldsmith SR, Masking GJ: Subpressor angiotensin II infusions do not stimulate sympathetic activity in humans. Am J Physiol 1990; 258:H179-H182
28. Goldsmith SR, Masking GJ: Effect of a pressor infusion of angiotensin II on sympathetic activity and heart rate in normal humans. Circ Res 1991;68:263-268
29. Francis GS: The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Am Heart J 1989; 118:642-648